300970.SZ
华绿生物
SZSE · A 农林牧渔 · CN
CNY 17.82
−7.09%Sep 4, 2026, 09:27 UTC
Hualv Bio's shareholder Yu Yangchao's stake was passively diluted to 29.91% due to the company's restricted stock incentive plan vesting.
Source:Aug 19, 2026, 10:23 UTC
Hualv Bio announced its first-half 2026 results: revenue of 694 million yuan, up 39.18% year-on-year; net profit attributable to shareholders of 46.0963 million yuan, turning around from a net loss of 53.6947 million yuan in the same period last year.
Source:Jul 3, 2026, 11:46 UTC
Hualv Biotechnology nominated Liu Zhiyu as an independent director candidate for its sixth board of directors.
Source: